5 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... chew, or crush tablet ... Note: Systemic antifungals ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
Overview of antifungal ... #valleyfever #management ... #treatment #antifungals ... #comparison #table ... #pharmacology
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
irrigation • Management ... Tolvaptan) • Treatment ... Excretion #Diuresis #Nephrology ... #Pharmacology # ... Medications #Table
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
Antifungal agents ... effects in the treatment ... and peripheral edema ... Coccidioidomycosis #pharmacology ... #management #treatment
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Infections in HIV-AIDS ... with ARV (see Table ... and itraconazole serum ... IDSA #Prevention #Treatment ... #management #opportunistic